Showing results (11-20 of 330) with videos related to

Sort By:
Pageof 33
Acta Medica Austriaca|January 1, 1983
[Emission-computed tomography of the myocardium with the 7-pinhole collimator]H Sochor, O Pachinger, E Ogris, et al.
Nuklearmedizin. Nuclear Medicine|October 1, 1978
Assessment of regional wall motion in coronary artery disease using radionuclide methodsE Ogris, O Pachinger, H Sochor, et al.
British Heart Journal|August 1, 1979
Assessment of left ventricular performance and myocardial viability using quantitative radioisotope techniquesO Pachinger, E Ogris, P Probst, et al.
Zeitschrift Fur Kardiologie|January 1, 1993
The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activatorK Huber, R Beckmann, F Rauscha, et al.
Thrombosis Research|September 15, 1989
Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatmentK Huber, I Resch, D Rosc, et al.
Thrombosis and Haemostasis|January 11, 1993
Influence of cardiac output on peak t-PA plasma levels in patients receiving thrombolytic therapy with recombinant tissue-type plasminogen activator--correlation with patency rateK Huber, R Beckmann, P Probst, et al.
Nephron|January 1, 1984
Chronic hemodialysis: high risk patients for arrhythmias?H Weber, C Schwarzer, H K Stummvoll, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Ketanserin combined with a beta-blocker or diuretic in essential hypertension. A multicentre studyC Bartoloni, P Dupont, H Feltkamp, et al.
Pacing and Clinical Electrophysiology : PACE|July 1, 1983
Electrophysiologic findings in carotid sinus massageP Probst, V Mühlberger, M Lederbauer, et al.
Thrombosis and Haemostasis|June 28, 1990
Plasminogen activator inhibitor-1 levels in patients with chronic angina pectoris with or without angiographic evidence of coronary sclerosisK Huber, I Resch, T Stefenelli, et al.
Pageof 33